Cargando…

Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report

Pasteurella multocida (P. multocida) infection develops in patients with chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids (ICS) are used for the treatment of COPD. Herein, we report a case of empyema caused by P. multocida in a patient using ICS for COPD. A 79-year-old man with...

Descripción completa

Detalles Bibliográficos
Autores principales: Odaka, Hidesato, Asahi, Ruriko, Shimada, Kengo, Kamei, Motonari, Kato, Taisei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027579/
https://www.ncbi.nlm.nih.gov/pubmed/36949977
http://dx.doi.org/10.7759/cureus.35156
_version_ 1784909733862309888
author Odaka, Hidesato
Asahi, Ruriko
Shimada, Kengo
Kamei, Motonari
Kato, Taisei
author_facet Odaka, Hidesato
Asahi, Ruriko
Shimada, Kengo
Kamei, Motonari
Kato, Taisei
author_sort Odaka, Hidesato
collection PubMed
description Pasteurella multocida (P. multocida) infection develops in patients with chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids (ICS) are used for the treatment of COPD. Herein, we report a case of empyema caused by P. multocida in a patient using ICS for COPD. A 79-year-old man with COPD presented with general fatigue. He was treated with triple therapy including ICS. Contrast-enhanced computed tomography revealed encapsulated pleural effusion in the left chest. We initiated antibiotics, sulbactam sodium/ampicillin sodium (3 g × 4), and thoracic drainage. His pleural effusion culture turned out positive and P. multocida was detected. The patient was diagnosed with empyema caused by P. multocida. The triple therapy combination, including ICS, was changed to a double therapy combination without ICS. The subsequent progress was relatively good, and on the 49th day of hospitalization, the patient was discharged. The onset of P. multocida infection may be associated with ICS use, which may best be avoided in a patient with COPD who is at risk of P. multocida infection.
format Online
Article
Text
id pubmed-10027579
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100275792023-03-21 Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report Odaka, Hidesato Asahi, Ruriko Shimada, Kengo Kamei, Motonari Kato, Taisei Cureus Infectious Disease Pasteurella multocida (P. multocida) infection develops in patients with chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids (ICS) are used for the treatment of COPD. Herein, we report a case of empyema caused by P. multocida in a patient using ICS for COPD. A 79-year-old man with COPD presented with general fatigue. He was treated with triple therapy including ICS. Contrast-enhanced computed tomography revealed encapsulated pleural effusion in the left chest. We initiated antibiotics, sulbactam sodium/ampicillin sodium (3 g × 4), and thoracic drainage. His pleural effusion culture turned out positive and P. multocida was detected. The patient was diagnosed with empyema caused by P. multocida. The triple therapy combination, including ICS, was changed to a double therapy combination without ICS. The subsequent progress was relatively good, and on the 49th day of hospitalization, the patient was discharged. The onset of P. multocida infection may be associated with ICS use, which may best be avoided in a patient with COPD who is at risk of P. multocida infection. Cureus 2023-02-18 /pmc/articles/PMC10027579/ /pubmed/36949977 http://dx.doi.org/10.7759/cureus.35156 Text en Copyright © 2023, Odaka et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Infectious Disease
Odaka, Hidesato
Asahi, Ruriko
Shimada, Kengo
Kamei, Motonari
Kato, Taisei
Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report
title Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report
title_full Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report
title_fullStr Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report
title_full_unstemmed Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report
title_short Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report
title_sort empyema caused by pasteurella multocida in a patient with chronic obstructive respiratory disease taking inhaled corticosteroids: a case report
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027579/
https://www.ncbi.nlm.nih.gov/pubmed/36949977
http://dx.doi.org/10.7759/cureus.35156
work_keys_str_mv AT odakahidesato empyemacausedbypasteurellamultocidainapatientwithchronicobstructiverespiratorydiseasetakinginhaledcorticosteroidsacasereport
AT asahiruriko empyemacausedbypasteurellamultocidainapatientwithchronicobstructiverespiratorydiseasetakinginhaledcorticosteroidsacasereport
AT shimadakengo empyemacausedbypasteurellamultocidainapatientwithchronicobstructiverespiratorydiseasetakinginhaledcorticosteroidsacasereport
AT kameimotonari empyemacausedbypasteurellamultocidainapatientwithchronicobstructiverespiratorydiseasetakinginhaledcorticosteroidsacasereport
AT katotaisei empyemacausedbypasteurellamultocidainapatientwithchronicobstructiverespiratorydiseasetakinginhaledcorticosteroidsacasereport